CONE ROD DYSTROPHY

This early-stage study tests a single injection of ACDN-01 into the eye for people with Stargardt disease or cone-rod dystrophy caused by ABCA4 gene mutations. The main goals are to check safety and find the best dose. About 15 adults with advanced vision loss will take part. The…

This study tests OpCT-001, a therapy made from special cells that may replace damaged light-sensing cells in the eye. It is for adults with inherited eye diseases like retinitis pigmentosa and Usher syndrome. The goal is to check safety and see if it can improve vision. About 54 …

This study uses a special camera called adaptive optics to take detailed pictures of the back of the eye in people with outer retinal diseases, such as age-related macular degeneration and retinitis pigmentosa. The goal is to develop new ways to diagnose and track these diseases.…

This study is a pre-screening step for people with Stargardt disease or cone-rod dystrophy caused by ABCA4 gene mutations. It uses genetic tests and eye exams to see who may qualify for upcoming ACDN-01 clinical trials. About 50 participants will be enrolled to confirm their diag…

This study looks at whether people with retinitis pigmentosa and similar eye diseases experience short-term improvements in vision after using a device that delivers mild electrical stimulation to the eye. The device is already approved in Europe to slow vision loss. Researchers …